Share Prices & Company Research

Stockbroking

Dechra Pharmaceuticals

Current Price 3870.00p Bid 3866.00p Ask 3870.00p Change 0.00%
Last Updated: 08/12/2025 23:40. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Financial Highlights Year Ended 30/06/2023

Revenue
£761.50m
Operating Profit/Loss
£6.30m
Dividend yield (%)
0.30
Total dividend for year
n/ap
Dividend cover
-1.97
P/E Ratio
n/a
More Financials

Key Personnel

Mr Paul Sandland
CFO & Executive Director
Mr Ian Page
Chief Executive Officer
Mr Alison Platt
Non-Executive Director
Mr Geeta Gopalan
Non-Executive Director
Mr John Shipsey
Non-Executive Director
Mr Lawson Macartney
Non-Executive Director
Mr Lisa Bright
Non-Executive Director

Stock Details

EPIC
DPHL
ISIN
GB0009633180
Shares in Issue
88.09m
Market cap
£3,409.18m

Analyst Views (5)

Strong Buy
 
20.00%
Buy
 
40.00%
Hold
 
40.00%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
3,870.00p
Bid Price
3,866.00p
Ask Price
3,870.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
3,870.00p
Previous Close
3,870.00p
Intraday High
3,870.00p
Intraday Low
3,870.00p
52 Week High
3,870.00p
52 Week Low
3,870.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

News

Income Statement

Year End Date
30 Jun 2023
30 Jun 2022
 
£ (M)
£ (M)
Continuing Operations
Revenue
761.50
681.80
Operating Profit/Loss
6.30
95.50
Net Interest
-41.50
-16.60
Pre-Tax Profit
-36.10
77.60
Profit After Tax from continuing operations
-27.90
58.20
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
-27.90
58.20
Attributable to:
Equity Holders of Parent Company
-27.90
58.20
Minority Interests
n/a
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
30 Jun 2023
30 Jun 2022
Basic
-24.59p
53.72p
Diluted
-24.59p
53.40p
Adjusted
-24.59p
121.57p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
30 Jun 2023
30 Jun 2022
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
159.30
100.30
Intangible Assets
922.40
730.50
Investment Properties
n/a
n/a
Investments
14.90
15.80
Other Financial Assets
n/a
n/a
Other Non-Current Assets
4.90
2.30
Current Assets
Inventories
217.30
175.70
Trade & Other Receivables
176.20
147.80
Cash at Bank & In Hand
74.40
120.90
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
1,569.40
1,293.30

Liabilities

Year End Date
30 Jun 2023
30 Jun 2022
 
£ (M)
£ (M)
Current Liabilities
Borrowings
3.90
3.30
Other Current Liabilities
160.10
155.40
Total Current Liabilities
164.00
158.70
Non-Current Liabilities
Borrowings
500.60
325.80
Provisions
78.00
38.00
Other Non-Current Liabilities
71.60
104.00
Total Non-Current Liabilities
650.20
467.80
Other Liabilities
n/a
n/a
Total Liabilities
814.20
626.50

Net Assets

Year End Date
30 Jun 2023
30 Jun 2022
 
£ (M)
£ (M)
Net Assets
755.20
666.80

Capital & Reserves

Year End Date
30 Jun 2023
30 Jun 2022
 
£ (M)
£ (M)
Share Capital
1.10
1.10
Share Premium Account
596.00
413.90
Other Reserves
71.50
87.80
Retained Earnings
86.60
164.00
Shareholders Funds
755.20
666.80
Minority Interests/Other Equity
n/a
n/a
Total Equity
755.20
666.80

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Interim
09 Mar 2023
13 Apr 2023
12.50p
Final
27 Oct 2022
18 Nov 2022
32.89p
Interim
03 Mar 2022
07 Apr 2022
12.00p
Final
28 Oct 2021
19 Nov 2021
29.39p
Interim
04 Mar 2021
07 Apr 2021
11.11p
Final
05 Nov 2020
27 Nov 2020
24.00p
Interim
05 Mar 2020
08 Apr 2020
10.29p
Final
24 Oct 2019
15 Nov 2019
22.10p
Interim
07 Mar 2019
08 Apr 2019
9.50p
Final
25 Oct 2018
16 Nov 2018
18.17p
Interim
08 Mar 2018
06 Apr 2018
7.33p
Final
26 Oct 2017
17 Nov 2017
15.33p
Interim
09 Mar 2017
07 Apr 2017
6.11p
Final
27 Oct 2016
18 Nov 2016
12.91p
Interim
10 Mar 2016
06 Apr 2016
5.55p
Final
29 Oct 2015
20 Nov 2015
11.82p
Interim
12 Mar 2015
07 Apr 2015
5.12p

Dividend Metrics

Year End Date
30 Jun 2023
30 Jun 2022
Dividend growth
-72.15%
10.84%
Dividend yield
0.30%
1.30%
Dividend cover
-1.97
2.71


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.